Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas
- Status
- WITHDRAWN
- Phase
- PHASE2
Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant,
- Status
- TERMINATED
- Phase
- PHASE3
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Participants With High Grade Primary Central Nervous System (CNS) Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access to Nivolumab (Opdivo)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
- Status
- WITHDRAWN
- Phase
- PHASE2